Literature DB >> 26746003

What Is Chronic or Persistent Diabetic Macular Edema and How Should It Be Treated?

Rajendra S Apte1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26746003     DOI： 10.1001/jamaophthalmol.2015.5469

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  7 in total

1.  FGF2-induced STAT3 activation regulates pathologic neovascularization.

Authors:  Zhenyu Dong; Andrea Santeford; Norimitsu Ban; Tae Jun Lee; Craig Smith; David M Ornitz; Rajendra S Apte
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

2.  Identification of time point to best define 'sub-optimal response' following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data.

Authors:  I Chatziralli; M Santarelli; N Patrao; L Nicholson; M Zola; R Rajendram; P Hykin; S Sivaprasad
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

Review 3.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 4.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

Review 5.  Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature.

Authors:  Habiba Saedon; Astha Anand; Yit C Yang
Journal:  Clin Ophthalmol       Date:  2017-03-27

6.  Combined SIRT3 and SIRT5 deletion is associated with inner retinal dysfunction in a mouse model of type 1 diabetes.

Authors:  Jonathan B Lin; Joseph B Lin; Howard C Chen; Teresa Chen; Rajendra S Apte
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

7.  Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor.

Authors:  Mutasem Elfalah; Saif Aldeen AlRyalat; Mario Damiano Toro; Robert Rejdak; Sandrine Zweifel; Rashed Nazzal; Mohammed Abu-Ameerh; Osama Ababneh; Almutez Gharaibeh; Zuhair Sharif; Jehad Meqbil; Mo'ath AlShawabkeh; Amal Alwreikat; Muawyah Al Bdour; Maysa Al-Hussaini; Yacoub A Yousef
Journal:  Clin Ophthalmol       Date:  2021-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.